Mendor

Helsinki, Finland Founded: 2006 • Age: 20 yrs Acquired By Glucostratus
Blood glucose monitoring systems are designed, developed, and commercialized.

About Mendor

Mendor is a company based in Helsinki (Finland) founded in 2006 was acquired by Glucostratus in June 2017. Mendor has raised $28.08 million across 4 funding rounds from investors including i-SENS, Life Sciences Partners and Finnvera. Mendor operates in a competitive market with competitors including Dexcom, Livongo, One Drop, Bigfoot Biomedical and mySugr, among others.

Key Metrics
  • Total Equity Funding
    $28.08M (USD)

    in 4 rounds

  • Latest Funding Round
    $1.19M (USD), Series C

    Mar 2016

  • Investors
    i-SENS

    & 5 more

  • Acquired by
    Glucostratus

    (Jun 2017)

Funding Insights of Mendor

Mendor has successfully raised a total of $28.08M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $1.19 million completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $28.08M
  • Total Rounds 4
  • Last Round Series C β€” $1.19M
  • First Round $11.66M

    (Jun 2011)

  • Investors Count 5

All 4 funding rounds of Mendor with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2016$1.19MSeries C––
Jul 2014$8.85MSeries C––
Jan 2014$6.39MSeries C––
–
Jun 2011$11.66MSeries B––
Valuation history

6 investors in total: 6 institutional.

Investors in Mendor

Mendor has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include i-SENS, Life Sciences Partners and Finnvera.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Alternative financing is provided by IPF Partners for healthcare.
–ipfpartners.comLuxembourg, Luxembourg
Private equity investments in life sciences businesses are managed.
1998lspvc.comAmsterdam, Netherlands
Private equity investment firm
–tesi.fiHelsinki, Finland
Blood glucose monitoring systems and clinical chemistry analyzers are developed.
2000i-sens.comZhangjiagang, China
Loans, investments, and financial services are provided to businesses.
1999finnvera.fiHelsinki, Finland
Remote monitoring solution for diabetes patients
2017glucostratus.comHelsinki, Finland
Premium access

Investor details for Mendor

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Mendor

4 dated milestones of Mendor across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded Mendor is founded.
  2. Funding First funding round of $11.7M.
  3. Funding Latest funding round, Series C, of $1.2M.
  4. Exit Acquired by Glucostratus.

Competitors of Mendor

Mendor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, One Drop, Bigfoot Biomedical and mySugr, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
dexcom.com1999San Diego, United States$52.5M9,600
Wearable glucose monitoring patches are provided for real-time data tracking.
livongo.com2014San Francisco, United States$245.2M3,263
Provider of smart devices for diabetes management for patients and doctors
onedrop.today2015New York, United States$107.87M166
Provider of workforce healthcare solutions
bigfootbiomedical.com2014Milpitas, United States$214.51M133
Developer of a closed-loop automated insulin delivery system
mysugr.com2012Vienna, Austria$4.8M–
Gamified apps for diabetes management and therapy are provided.
senseonics.com1996Germantown, United States$175.46M132
Implantable continuous glucose monitoring systems are provided for diabetes management.
janacare.com2011Newton, United States$26.59M–
Mobile-based diagnostics for diabetes prevention and management are provided.
telcare.com2008Bethesda, United States$66.69M21
Diabetes is managed via cellular technology and social networking.
caura.com2016London, United Kingdom$4.2M11
Auto insurance and vehicle services are provided via mobile app.
presspogo.com2002San Francisco, United States$258.45M131
An all-in-one blood glucose monitoring system is developed and offered.
Premium access

Detailed competitors of Mendor

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Mendor

Websites that share an audience with Mendor (mendor.com).

Similar websites

Websites whose visitors overlap most with Mendor. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
en.wikipedia.org
en.wikipedia.org
100%
–––
ovelin.com
ovelin.com
96%
–––
youtube.com
69%
30.4B#2View details

Latest news on Mendor

Premium access

Complete news archive for Mendor

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Mendor

10 companies that operate in the same segment as Mendor (Diabetes), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of devices for continuous glucose monitoring and manual insulin delivery
2008San Diego, California, United StatesUSD 100.73 MUSD 1.02 B2,650
Wearable glucose monitoring patches are provided for real-time data tracking.
1999San Diego, California, United StatesUSD 52.5 MUSD 4.66 B10,300
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Small molecule drugs for various therapeutic areas are developed.
1995United StatesUSD 165 MUSD 49.8 M103
Implantable continuous glucose monitoring systems are provided for diabetes management.
1996Germantown, United StatesUSD 175.46 MUSD 22.47 M117
Developer of a closed-loop automated insulin delivery system
2014Milpitas, California, United StatesUSD 214.51 M–133
Provider of workforce healthcare solutions
2015New York, New York, United StatesUSD 107.87 M–166
Diabetes care and reversal programs are provided to patients.
2021Bengaluru, Karnataka, IndiaUSD 26.7 MUSD 5.07 M677
Provider of smart devices for diabetes management for patients and doctors
2014San Francisco, California, United StatesUSD 245.2 M––
Genetically engineered cell therapies are developed for multiple disorders.
2018Seattle, Washington, United StatesUSD 821 M–194
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Mendor

Mendor was founded in 2006 and raised its 1st funding round 5 years after it was founded.

Mendor is headquartered in Helsinki, Finland.

Mendor is a funded company, having raised a total of $28.08M across 4 funding rounds to date. The company's 1st funding round was a Series B of $11.66M, raised on Jun 2011.

Mendor is a startup which has designed, developed and commercializes glucose monitoring system. Offers the Discreet blood-glucose meter and Balance online software. Discreet is described as an all-in-one blood-glucose monitoring system, while Balance is a cloud-based data-analysis platform that allows users to store and share individual data on glucose-levels. Integrates all - blood glucose meter, test strips and a lancing pen into one device.

Mendor's top competitors include Dexcom, Senseonics and Bigfoot Biomedical.

Mendor has 6 investors. Key investors include i-SENS, Life Sciences Partners, Finnvera, Glucostratus, and IPF Partners.

Yes. Mendor was acquired by Glucostratus in June 2017.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available